AVITA Medical Inc (RCEL): Next-Year EPS Estimate 37.58%
As of 2026-06-04, AVITA Medical Inc (RCEL) has a next-year EPS growth estimate of 37.58%.
On 2026-05-31, analyst consensus for RCEL's next-year EPS growth shifted from 57.04% to 37.58% — a negative change of 19.46 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 36.58%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 37.58%
- EPS growth this year
- 36.58%
- EPS next quarter (est)
- -$0.31
- Last price
- $4.36
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 37.58% | 36.58% | -$0.31 | $4.36 |
| 2026-06-03 | 37.58% | 36.58% | -$0.31 | $4.16 |
| 2026-06-02 | 37.58% | 36.58% | -$0.31 | $4.19 |
| 2026-06-01 | 37.58% | 36.58% | -$0.31 | $4.38 |
| 2026-05-31 | 37.58% | 36.58% | -$0.31 | $4.33 |
| 2026-05-28 | 57.04% | 39.35% | -$0.29 | $4.39 |
| 2026-05-27 | 57.04% | 39.35% | -$0.29 | $4.20 |
| 2026-05-26 | 57.04% | 39.35% | -$0.29 | $4.25 |
| 2026-05-25 | 57.04% | 39.35% | -$0.29 | $4.58 |
| 2026-05-24 | 57.04% | 39.35% | -$0.29 | $4.58 |
| 2026-05-21 | 57.04% | 39.35% | -$0.29 | $4.48 |
| 2026-05-20 | 57.04% | 39.35% | -$0.29 | $4.32 |
| 2026-05-19 | 57.04% | 39.35% | -$0.29 | $4.20 |
| 2026-05-18 | 57.04% | 39.35% | -$0.29 | $4.19 |
| 2026-05-17 | 58.31% | 39.77% | -$0.28 | $4.56 |
| 2026-05-14 | 62.13% | 42.75% | -$0.29 | $4.36 |
| 2026-05-13 | 62.13% | 42.75% | -$0.29 | $4.34 |
| 2026-05-12 | 62.13% | 42.75% | -$0.29 | $4.38 |
| 2026-05-11 | 62.13% | 42.75% | -$0.29 | $4.37 |
| 2026-05-10 | 62.13% | 42.75% | -$0.29 | $4.11 |
| 2026-05-07 | 62.13% | 42.75% | -$0.29 | $4.18 |
| 2026-05-06 | 62.13% | 42.75% | -$0.29 | $4.42 |
| 2026-05-05 | 62.13% | 42.75% | -$0.29 | $4.24 |
| 2026-05-04 | 62.13% | 42.75% | -$0.29 | $4.28 |
| 2026-05-03 | 62.13% | 42.75% | -$0.29 | $4.44 |
| 2026-04-30 | 62.13% | 42.75% | -$0.29 | $4.32 |
| 2026-04-29 | 62.13% | 42.75% | -$0.29 | $4.23 |
| 2026-04-28 | 62.13% | 42.75% | -$0.29 | $4.33 |
| 2026-04-27 | 62.13% | 42.75% | -$0.29 | $4.56 |
| 2026-04-26 | 62.13% | 42.75% | -$0.29 | $4.46 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is AVITA Medical Inc's next-year EPS growth estimate?▾
As of 2026-06-04, AVITA Medical Inc (RCEL) has a next-year EPS growth estimate of 37.58%, based on analyst consensus.
When was the latest EPS estimate revision for RCEL?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 57.04% to 37.58%.
What sector and industry does AVITA Medical Inc belong to?▾
AVITA Medical Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RCEL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. AVITA Medical Inc (RCEL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports